Stock BFRG BULLFROG AI HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Bullfrog AI Holdings, Inc.

Equities

BFRG

US12021E1091

Biotechnology & Medical Research

Market Closed - Nasdaq
Other stock markets
 15:59:55 2024-05-22 EDT 		5-day change 1st Jan Change
3.05 USD -0.65% Intraday chart for Bullfrog AI Holdings, Inc. 0.00% -6.44%
05-16 Bullfrog AI Holdings, Inc. and Lieber Institute for Brain Development Collaboration Identifies Novel Drug Targets for Neuropsychiatric Disorders CI
05-10 Bullfrog AI Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Valuation

Fiscal Period: December 2023
Capitalization 1 19.87
Enterprise Value (EV) 1 17.24
P/E ratio -3.68 x
Yield -
Capitalization / Revenue 305,669,831 x
EV / Revenue 265,289,369 x
EV / EBITDA -3,213,652 x
EV / FCF -4,099,434 x
FCF Yield -0%
Price to Book 7.66 x
Nbr of stocks (in thousands) 6,095
Reference price 2 3.260
Announcement Date 3/29/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023
Net sales - - 0.01 0.065
EBITDA - - -2.455 -5.366
EBIT 1 -0.3472 -0.5554 -2.456 -5.368
Operating Margin - - -24,558.01% -8,257.73%
Earnings before Tax (EBT) 1 -0.3417 -0.5858 -2.802 -5.356
Net income 1 -0.3417 -0.5858 -2.802 -5.356
Net margin - - -28,024.87% -8,239.8%
EPS 2 -0.0964 -0.1568 -0.6989 -0.8853
Free Cash Flow - -0.1635 0.096 -4.206
FCF margin - - 960.33% -6,471.37%
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 6/10/22 6/10/22 4/25/23 3/29/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023
Net Debt 1 0.2 0.58 1.52 -
Net Cash position 1 - - - 2.62
Leverage (Debt/EBITDA) - - -0.6196 x -
Free Cash Flow - -0.16 0.1 -4.21
ROE (net income / shareholders' equity) - 75.6% 138% 2,303%
ROA (Net income/ Total Assets) - -4,618% -3,396% -235%
Assets 1 - 0.0127 0.0825 2.281
Book Value Per Share 2 -0.1500 -0.2600 -0.7600 0.4300
Cash Flow per Share 2 0 0 0.0100 0.4300
Capex - - 0.01 -
Capex / Sales - - 87.44% -
Announcement Date 6/10/22 6/10/22 4/25/23 3/29/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
BULLFROG AI HOLDINGS, INC. Stock Bullfrog AI Holdings, Inc.
-6.44% 23.94M
MODERNA, INC. Stock Moderna, Inc.
+64.23% 62.59B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-2.31% 41.18B
LONZA GROUP AG Stock Lonza Group AG
+44.36% 40.29B
CELLTRION, INC. Stock Celltrion, Inc.
-8.29% 27.9B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+11.97% 26.21B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-21.16% 19.09B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+7.54% 13.08B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+27.17% 12.05B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+25.72% 12.26B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. BFRG Stock
  4. Financials Bullfrog AI Holdings, Inc.